FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1179089005: Tivozanib hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4649401010 Tivozanib hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4649402015 Tivozanib hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tivozanib hydrochloride Is a Antineoplastic agent (substance) true Inferred relationship Some
Tivozanib hydrochloride Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Tivozanib hydrochloride Is a Enzyme inhibitor false Inferred relationship Some
Tivozanib hydrochloride Is a Quinoline true Inferred relationship Some
Tivozanib hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Tivozanib hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tivozanib (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Tivozanib hydrochloride monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tivozanib hydrochloride Inferred relationship Some
Product containing precisely tivozanib (as tivozanib hydrochloride) 890 microgram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tivozanib hydrochloride Inferred relationship Some 1
Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tivozanib hydrochloride Inferred relationship Some 1
Tivozanib hydrochloride anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tivozanib hydrochloride Inferred relationship Some

This concept is not in any reference sets

Back to Start